TABLE 1

Baseline characteristics of study participants

Intervention groupControl groupP*PP
Age (years) 54 ± 8 (52) 53 ± 7 (49) 0.615   
Weight (kg) 86.1 ± 14.2 (52) 87.8 ± 15.7 (49) 0.634 0.945  
BMI (kg/m230.9 ± 4.0 (52) 31.7 ± 5.0 (49) 0.596 0.740  
Waist circumference (cm) 104.3 ± 10.6 (51) 104.0 ± 10.9 (49) 0.981 0.689 0.134 
Fasting glucose (mmol/l) 6.3 ± 0.8 (51) 6.5 ± 0.8 (49) 0.262 0.159 0.182 
2-h glucose (mmol/l) 9.1 ± 1.5 (51) 9.3 ± 1.7 (49) 0.612 0.610 0.631 
Fasting insulin (pmol/l) 83.5 ± 38.0 (49) 103.6 ± 58.6 (48) 0.134 0.110 0.128 
2-h insulin (pmol/l) 616.3 ± 411.6 (38) 632.2 ± 402.0 (36) 0.746 0.726 0.855 
HbA1c (%) 5.9 ± 0.9 (50) 5.8 ± 1.0 (47) 0.657 0.681 0.688 
AIR (mU · l−1 · min−1281 ± 286 (47) 259 ± 266 (40) 0.762 0.584 0.585 
Si (×10−4 · min−1 · μU−1 · ml−11.85 ± 1.28 (47) 1.99 ± 1.38 (39) 0.588 0.648 0.632 
Sg ([min]−1 · 1021.50 ± 0.51 (47) 1.52 ± 0.48 (40) 0.936 0.841 0.828 
Intervention groupControl groupP*PP
Age (years) 54 ± 8 (52) 53 ± 7 (49) 0.615   
Weight (kg) 86.1 ± 14.2 (52) 87.8 ± 15.7 (49) 0.634 0.945  
BMI (kg/m230.9 ± 4.0 (52) 31.7 ± 5.0 (49) 0.596 0.740  
Waist circumference (cm) 104.3 ± 10.6 (51) 104.0 ± 10.9 (49) 0.981 0.689 0.134 
Fasting glucose (mmol/l) 6.3 ± 0.8 (51) 6.5 ± 0.8 (49) 0.262 0.159 0.182 
2-h glucose (mmol/l) 9.1 ± 1.5 (51) 9.3 ± 1.7 (49) 0.612 0.610 0.631 
Fasting insulin (pmol/l) 83.5 ± 38.0 (49) 103.6 ± 58.6 (48) 0.134 0.110 0.128 
2-h insulin (pmol/l) 616.3 ± 411.6 (38) 632.2 ± 402.0 (36) 0.746 0.726 0.855 
HbA1c (%) 5.9 ± 0.9 (50) 5.8 ± 1.0 (47) 0.657 0.681 0.688 
AIR (mU · l−1 · min−1281 ± 286 (47) 259 ± 266 (40) 0.762 0.584 0.585 
Si (×10−4 · min−1 · μU−1 · ml−11.85 ± 1.28 (47) 1.99 ± 1.38 (39) 0.588 0.648 0.632 
Sg ([min]−1 · 1021.50 ± 0.51 (47) 1.52 ± 0.48 (40) 0.936 0.841 0.828 

Data are mean ± SD (n).

*

P value after adjustment for age and sex.

P value after adjustment for age, sex, and BMI.

Close Modal

or Create an Account

Close Modal
Close Modal